ANDRES MANUEL R
CERVANTES RUIPEREZ
CATEDRÁTICO/A DE UNIVERSIDAD
Mayo Clinic
Rochester, Estados UnidosPublikationen in Zusammenarbeit mit Forschern von Mayo Clinic (6)
2022
-
ESMO Expert Consensus Statements on Cancer Survivorship: promoting high-quality survivorship care and research in Europe
Annals of Oncology, Vol. 33, Núm. 11, pp. 1119-1133
2018
-
CanStem303C trial: A Phase 3 Study of napabucasin (NAPA) in combination with 5-fluorouracil (5-FU), leucovorin, and irinotecan (FOLFIRI) in adult patients (pts) with previously treated metastatic colorectal cancer (mCRC) - Trial in progress
Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 29, pp. v84
2017
-
Clinicopathological factors influence diagnostic accuracy of clinical N staging for early gastric cancer
Annals of Oncology, Vol. 28, pp. iii135-iii136
2016
-
ESMO consensus guidelines for the management of patients with metastatic colorectal cancer
Annals of Oncology, Vol. 27, Núm. 8, pp. 1386-1422
2011
2003
-
Gastric cancer: Epidemiology, pathology and treatment
Annals of Oncology, Vol. 14, Núm. SUPPL. 2